Hamilton Thorne (CVE:HTL) Shares Up 4.3% – What’s Next?

Hamilton Thorne Ltd. (CVE:HTLGet Free Report)’s share price shot up 4.3% during mid-day trading on Monday . The stock traded as high as C$1.45 and last traded at C$1.45. Approximately 25,700 shares were traded during trading, a decline of 27% from the average daily volume of 35,118 shares. The stock had previously closed at C$1.39.

Hamilton Thorne Price Performance

The firm’s fifty day moving average price is C$1.45 and its 200 day moving average price is C$1.45. The company has a quick ratio of 2.25, a current ratio of 2.04 and a debt-to-equity ratio of 43.24. The stock has a market cap of C$149.69 million, a PE ratio of 58.94 and a beta of 0.54.

About Hamilton Thorne

(Get Free Report)

Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets. The company also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services.

Featured Stories

Receive News & Ratings for Hamilton Thorne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hamilton Thorne and related companies with MarketBeat.com's FREE daily email newsletter.